NCT01974739 is a NA clinical trial of Hydrochloorthiazide in Hypernatraemia, sponsored by Frisius Medisch Centrum.

Who is sponsoring NCT01974739?

NCT01974739 is sponsored by Frisius Medisch Centrum.

What drugs are being tested in NCT01974739?

Interventions in NCT01974739: Hydrochloorthiazide, placebo.

What condition does NCT01974739 study?

NCT01974739 studies Hypernatraemia.

Is NCT01974739 still recruiting?

NCT01974739 is currently completed. Last updated 22 June 2015.

Last reviewed 2015-06-22 · How we verify

NCT01974739

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hypernatraemia and Diuretics in Intensive Care Patients

Completed NA Last updated 22 June 2015

What this trial tests

NA trial testing Hydrochloorthiazide in Hypernatraemia in 50 participants. Completed in 1 May 2015.

Timeline

1 September 2013

Primary endpoint
1 May 2015

1 May 2015

Quick facts

Lead sponsor	Frisius Medisch Centrum
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	quadruple
Primary purpose	treatment
Enrollment	50
Start date	1 September 2013
Primary completion	1 May 2015
Estimated completion	1 May 2015
Sites	1 location across Netherlands

Drugs / interventions tested

Hydrochloorthiazide — full drug profile →
placebo

Conditions studied

Hypernatraemia — all drugs for Hypernatraemia →

Sponsor

Frisius Medisch Centrum — full company profile →

Who can join

18 and older, any sex, with Hypernatraemia. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

sodium level
Time frame: 7 days
a decrease of 5 mmol/L sodium in plama

Sponsor's own description

Acquired hypernatremia appears to be associated with mortallity in ICU. To reduce hypernatremia and shorten the time of hypernatremia, we investigate the effect of hydrochloorthiazide compared to a placebo

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Frisius Medisch Centrum trials

Trials by the same sponsor.

NCT06249035 — Feasibility of TEE During Cardiac Arrest in Dutch Emergency Departments · NA · recruiting
NCT06558630 — ED Airway Management in the Netherlands. · recruiting
NCT06202729 — Focus on Experienced Anxiety Related to an Emergency Department Visit · completed
NCT05732363 — Evaluation of Different Methods to Measure Muscle Mass and Strength in a Population With Class II/III Obesity · completed
NCT06119711 — Micronutrient Levels and Nutritional Status in Critical Illness · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01974739 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Frisius Medisch Centrum
Last refreshed: 22 June 2015

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01974739.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing